⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Muna Therapeutics and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Muna Therapeutics
↗Frederiksberg, Denmark
Muna Therapeutics is a clinical-stage biotechnology company focused on discovering and developing disease-modifying small molecule therapies for neurodegenerative disorders, including Alzheimer's, Parkinson's, and frontotemporal dementia. The company leverages its proprietary 'MiND-MAP' all-in-human target discovery and validation platform, which integrates single-cell spatial multi-omics and bioinformatics to identify molecular pathways that underlie disease resilience.
Founded in 2020 through the combination of two European start-ups and supported by major investors like Novo Holdings, Muna aims to shift the treatment paradigm from traditional amyloid/tau-focused approaches to enhancing the brain's innate protective mechanisms, such as microglial function. The company operates out of Copenhagen, Denmark, and maintains a collaborative research model with academic and industry partners.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:-
Industry:Biotechnology
Sub-Industry:Neurodegenerative diseases
SIZE & FINANCIALS
Employees:51-200
Revenue:$1M-$5M
Founded:2020
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$73M
Investors:Novo Holdings, Sofinnova Partners, Droia Ventures, LSP Dementia Fund, Polaris Partners, Sanofi Ventures, V-Bio Ventures, VIB
PIPELINE
Stage:Phase 1
Lead Drug Stage:Phase 1
Modalities:Small molecule
Active Trials:1
Trial Phases:Phase 1: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:GSK (Collaboration to identify and validate Alzheimer's drug targets using MiND-MAP platform)
COMPETITION
Position:Emerging
Competitors:Neuropore Therapies, Aelin Therapeutics, Neumirna Therapeutics
LEADERSHIP
Key Executives:
Rita Balice-Gordon - CEO
Anders Hinsby - COO
Niels Plath - CSO
Scientific Founders:Simon Glerup, Bart De Strooper
Board Members:Donald Nicholson, Luc Dochez, Camilla Hansen, Laia Crespo-Martin, Henrijette Richter, Eileen McGuire, Cillian King
LINKS
Website:munatherapeutics.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Muna Therapeutics. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.